Global Orphan Diseases Partnering Directory 2018: Deals Signed Between the Worlds Pharmaceutical and Biotechnology Companies Since 2012
Summary
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensors product or technology.More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.In addition, a comprehensive appendix is provided with each report of all Orphan Diseases partnering deals signed and announced since 2012.The report also includes numerous tables and figures that illustrate the trends and activities in Orphan Diseases partnering and dealmaking since 2012.In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Orphan Diseases technologies and products.